- call +1-201-465-4211
- email sales@mrinsights.biz
Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 22 in 2017.
Scope of the Report:
This report focuses on the Polio Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The prevalence of Polio disease is key driver to lead to growth of polio vaccines market. mainly affects children under 5 years of age. Up to 70% of all the infections in children are without any symptoms and about 25-30% of infections in children causes’ nonspecific illness without clinical or laboratory evidence of central nervous system invasion. This has created a gesture for the organizations to focus on the vaccines options for making prophylactic approach towards the prevention of the disorder, which in turn is expected to fuel the polio vaccines market in the near future. As far as the geography is concerned, North American is currently leading the market, the reason being initiatives laid down by the government for encouraging the adoption of immunization against diseases like influenza and HPV.
The worldwide market for Polio Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
CSL
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
IPV
OPV
Market Segment by Applications, can be divided into
Age (0-1)
Age Above 1
There are 15 Chapters to deeply display the global Polio Vaccines market.
Chapter 1, to describe Polio Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Polio Vaccines, with sales, revenue, and price of Polio Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Polio Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Polio Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Polio Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Polio Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 IPV
1.2.2 OPV
1.3 Market Analysis by Applications
1.3.1 Age (0-1)
1.3.2 Age Above 1
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL
2.1.1 Business Overview
2.1.1.1 CSL Description
2.1.1.2 CSL Headquarter, Main Business and Finance Overview
2.1.2 CSL Polio Vaccines Product Introduction
2.1.2.1 Polio Vaccines Production Bases, Sales Regions and Major Competitors
2.1.2.2 Polio Vaccines Product Information
2.1.3 CSL Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 CSL Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global CSL Polio Vaccines Market Share in 2017
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.1.1 GlaxoSmithKline Description
2.2.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.2.2 GlaxoSmithKline Polio Vaccines Product Introduction
2.2.2.1 Polio Vaccines Production Bases, Sales Regions and Major Competitors
2.2.2.2 Polio Vaccines Product Information
2.2.3 GlaxoSmithKline Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 GlaxoSmithKline Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global GlaxoSmithKline Polio Vaccines Market Share in 2017
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.1.1 Johnson & Johnson Description
2.3.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.3.2 Johnson & Johnson Polio Vaccines Product Introduction
2.3.2.1 Polio Vaccines Production Bases, Sales Regions and Major Competitors
2.3.2.2 Polio Vaccines Product Information
2.3.3 Johnson & Johnson Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Johnson & Johnson Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Johnson & Johnson Polio Vaccines Market Share in 2017
2.4 MedImmune
2.4.1 Business Overview
2.4.1.1 MedImmune Description
2.4.1.2 MedImmune Headquarter, Main Business and Finance Overview
2.4.2 MedImmune Polio Vaccines Product Introduction
2.4.2.1 Polio Vaccines Production Bases, Sales Regions and Major Competitors
2.4.2.2 Polio Vaccines Product Information
2.4.3 MedImmune Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 MedImmune Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global MedImmune Polio Vaccines Market Share in 2017
2.5 Merck
2.5.1 Business Overview
2.5.1.1 Merck Description
2.5.1.2 Merck Headquarter, Main Business and Finance Overview
2.5.2 Merck Polio Vaccines Product Introduction
2.5.2.1 Polio Vaccines Production Bases, Sales Regions and Major Competitors
2.5.2.2 Polio Vaccines Product Information
2.5.3 Merck Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Merck Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Merck Polio Vaccines Market Share in 2017
2.6 Pfizer
2.6.1 Business Overview
2.6.1.1 Pfizer Description
2.6.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.6.2 Pfizer Polio Vaccines Product Introduction
2.6.2.1 Polio Vaccines Production Bases, Sales Regions and Major Competitors
2.6.2.2 Polio Vaccines Product Information
2.6.3 Pfizer Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Pfizer Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Pfizer Polio Vaccines Market Share in 2017
2.7 Sanofi Pasteur
2.7.1 Business Overview
2.7.1.1 Sanofi Pasteur Description
2.7.1.2 Sanofi Pasteur Headquarter, Main Business and Finance Overview
2.7.2 Sanofi Pasteur Polio Vaccines Product Introduction
2.7.2.1 Polio Vaccines Production Bases, Sales Regions and Major Competitors
2.7.2.2 Polio Vaccines Product Information
2.7.3 Sanofi Pasteur Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Sanofi Pasteur Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Sanofi Pasteur Polio Vaccines Market Share in 2017
2.8 Serum Institute
2.8.1 Business Overview
2.8.1.1 Serum Institute Description
2.8.1.2 Serum Institute Headquarter, Main Business and Finance Overview
2.8.2 Serum Institute Polio Vaccines Product Introduction
2.8.2.1 Polio Vaccines Production Bases, Sales Regions and Major Competitors
2.8.2.2 Polio Vaccines Product Information
2.8.3 Serum Institute Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Serum Institute Polio Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Serum Institute Polio Vaccines Market Share in 2017
3 Global Polio Vaccines Market Competition, by Manufacturer
3.1 Global Polio Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Polio Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Polio Vaccines Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Polio Vaccines Manufacturer Market Share in 2017
3.4.2 Top 5 Polio Vaccines Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Polio Vaccines Market Analysis by Regions
4.1 Global Polio Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Polio Vaccines Sales by Regions (2013-2018)
4.1.2 Global Polio Vaccines Revenue by Regions (2013-2018)
4.2 North America Polio Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Polio Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Polio Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Polio Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Polio Vaccines Sales, Revenue and Growth Rate (2013-2018)
5 North America Polio Vaccines by Countries, Type, Application and Manufacturers
5.1 North America Polio Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Polio Vaccines Sales by Countries (2013-2018)
5.1.2 North America Polio Vaccines Revenue by Countries (2013-2018)
5.1.3 United States Polio Vaccines Sales and Growth Rate (2013-2018)
5.1.4 Canada Polio Vaccines Sales and Growth Rate (2013-2018)
5.1.5 Mexico Polio Vaccines Sales and Growth Rate (2013-2018)
5.2 North America Polio Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Polio Vaccines Sales by Manufacturers (2016-2017)
5.2.2 North America Polio Vaccines Revenue by Manufacturers (2016-2017)
5.3 North America Polio Vaccines Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Polio Vaccines Sales and Sales Share by Type (2013-2018)
5.3.2 North America Polio Vaccines Revenue and Revenue Share by Type (2013-2018)
5.4 North America Polio Vaccines Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Polio Vaccines Sales and Sales Share by Application (2013-2018)
5.4.2 North America Polio Vaccines Revenue and Revenue Share by Application (2013-2018)
6 Europe Polio Vaccines by Countries, Type, Application and Manufacturers
6.1 Europe Polio Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Polio Vaccines Sales by Countries (2013-2018)
6.1.2 Europe Polio Vaccines Revenue by Countries (2013-2018)
6.1.3 Germany Polio Vaccines Sales and Growth Rate (2013-2018)
6.1.4 UK Polio Vaccines Sales and Growth Rate (2013-2018)
6.1.5 France Polio Vaccines Sales and Growth Rate (2013-2018)
6.1.6 Russia Polio Vaccines Sales and Growth Rate (2013-2018)
6.1.7 Italy Polio Vaccines Sales and Growth Rate (2013-2018)
6.2 Europe Polio Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Polio Vaccines Sales by Manufacturers (2016-2017)
6.2.2 Europe Polio Vaccines Revenue by Manufacturers (2016-2017)
6.3 Europe Polio Vaccines Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Polio Vaccines Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Polio Vaccines Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Polio Vaccines Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Polio Vaccines Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Polio Vaccines Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Polio Vaccines by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Polio Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Polio Vaccines Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Polio Vaccines Revenue by Countries (2013-2018)
7.1.3 China Polio Vaccines Sales and Growth Rate (2013-2018)
7.1.4 Japan Polio Vaccines Sales and Growth Rate (2013-2018)
7.1.5 Korea Polio Vaccines Sales and Growth Rate (2013-2018)
7.1.6 India Polio Vaccines Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Polio Vaccines Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Polio Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Polio Vaccines Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Polio Vaccines Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Polio Vaccines Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Polio Vaccines Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Polio Vaccines Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Polio Vaccines Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Polio Vaccines Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Polio Vaccines Revenue and Revenue Share by Application (2013-2018)
8 South America Polio Vaccines by Countries, Type, Application and Manufacturers
8.1 South America Polio Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Polio Vaccines Sales by Countries (2013-2018)
8.1.2 South America Polio Vaccines Revenue by Countries (2013-2018)
8.1.3 Brazil Polio Vaccines Sales and Growth Rate (2013-2018)
8.1.4 Argentina Polio Vaccines Sales and Growth Rate (2013-2018)
8.1.5 Colombia Polio Vaccines Sales and Growth Rate (2013-2018)
8.2 South America Polio Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Polio Vaccines Sales by Manufacturers (2016-2017)
8.2.2 South America Polio Vaccines Revenue by Manufacturers (2016-2017)
8.3 South America Polio Vaccines Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Polio Vaccines Sales and Sales Share by Type (2013-2018)
8.3.2 South America Polio Vaccines Revenue and Revenue Share by Type (2013-2018)
8.4 South America Polio Vaccines Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Polio Vaccines Sales and Sales Share by Application (2013-2018)
8.4.2 South America Polio Vaccines Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Polio Vaccines by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Polio Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Polio Vaccines Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Polio Vaccines Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Polio Vaccines Sales and Growth Rate (2013-2018)
9.1.4 UAE Polio Vaccines Sales and Growth Rate (2013-2018)
9.1.5 Egypt Polio Vaccines Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Polio Vaccines Sales and Growth Rate (2013-2018)
9.1.7 South Africa Polio Vaccines Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Polio Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Polio Vaccines Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Polio Vaccines Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Polio Vaccines Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Polio Vaccines Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Polio Vaccines Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Polio Vaccines Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Polio Vaccines Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Polio Vaccines Revenue and Revenue Share by Application (2013-2018)
10 Global Polio Vaccines Market Segment by Type
10.1 Global Polio Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Polio Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global Polio Vaccines Revenue and Market Share by Type (2013-2018)
10.2 IPV Sales Growth and Price
10.2.1 Global IPV Sales Growth (2013-2018)
10.2.2 Global IPV Price (2013-2018)
10.3 OPV Sales Growth and Price
10.3.1 Global OPV Sales Growth (2013-2018)
10.3.2 Global OPV Price (2013-2018)
11 Global Polio Vaccines Market Segment by Application
11.1 Global Polio Vaccines Sales Market Share by Application (2013-2018)
11.2 Age (0-1) Sales Growth (2013-2018)
11.3 Age Above 1 Sales Growth (2013-2018)
12 Polio Vaccines Market Forecast (2018-2023)
12.1 Global Polio Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Polio Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America Polio Vaccines Market Forecast (2018-2023)
12.2.2 Europe Polio Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific Polio Vaccines Market Forecast (2018-2023)
12.2.4 South America Polio Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa Polio Vaccines Market Forecast (2018-2023)
12.3 Polio Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global Polio Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global Polio Vaccines Market Share Forecast by Type (2018-2023)
12.4 Polio Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global Polio Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global Polio Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Polio Vaccines Picture
Table Product Specifications of Polio Vaccines
Figure Global Polio Vaccines CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
